![Timothy Lynch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Lynch
Geen lopende functies
Vermogen: 33 M $ op 30-09-2026
Profiel
Mr. Timothy P.
Lynch was previously employed as an Independent Director by InSite Vision, Inc., a Managing Member by Stonepine Capital Management LLC, an Independent Director by Nabi Biopharmaceuticals, an Independent Director by Allos Therapeutics, Inc., a President & Chief Executive Officer by Neurostat Pharmaceuticals, Inc., a President & Chief Executive Officer by Vivo Therapeutics, Inc., a Chief Financial Officer by Tercica, Inc., a Chief Financial Officer by InterMune, Inc., a Principal by Goldman Sachs & Co. LLC, and an Advisor by Healthcare Royalty Management LLC.
He also served on the board at Aradigm Corp., BioForm Medical, Inc., ClearFlow, Inc. and Elan Corp.
Plc.
He received his undergraduate degree from Colgate University and an MBA from Harvard University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Evolus, Inc.
 Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins 5,93% | 17-04-2026 | 3.835.363 ( 5,93% ) | 31 M $ | 30-09-2026 |
AEON Biopharma, Inc.
 AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets 13,03% | 19-08-2026 | 6.500.000 ( 13,03% ) | 2 M $ | 30-09-2026 |
Eerdere bekende functies van Timothy Lynch
| Bedrijven | Functie | Einde |
|---|---|---|
Stonepine Capital Management LLC
 Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Director of Investments | 01-09-2024 |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Directeur/Bestuurslid | 31-12-2011 |
| INSITE VISION INC. | Directeur/Bestuurslid | 16-09-2011 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Directeur/Bestuurslid | 04-06-2009 |
BioForm Medical, Inc.
 BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation | Directeur/Bestuurslid | 19-02-2010 |
Opleiding van Timothy Lynch
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
16
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 16 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products | Health Technology |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
InterMune, Inc.
 InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
BioForm Medical, Inc.
BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation | Health Technology |
ClearFlow, Inc.
 ClearFlow, Inc. Medical SpecialtiesHealth Technology Develops ICU surgical and medical devices | Health Technology |
Stonepine Capital Management LLC
Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
Neurostat Pharmaceuticals, Inc. | |
Vivo Therapeutics, Inc. |
